Oxetacaine
- Generic Name
- Oxetacaine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C28H41N3O3
- CAS Number
- 126-27-2
- Unique Ingredient Identifier
- IP8QT76V17
- Background
Oxetacaine, also called oxethazaince, is a potent surface analgesic with the molecular formula N, N-bis-(N-methyl-N-phenyl-t-butyl-acetamide)-beta-hydroxyethylamine that conserves its unionized form at low pH levels. Its actions have shown to relieve dysphagia, relieve pain due to reflux, chronic gastritis, and duodenal ulcer. Oxetacaine is approved by Healt...
- Indication
Oxetacaine is available as an over-the-counter antacid and it is used to alleviate pain associated with gastritis, peptic ulcer disease, heartburn, esophagitis, hiatus hernia, and anorexia.
- Associated Conditions
- Fissure;Anal, Haemorrhoids, Proctitis, Pruritus Ani, Reflux Acid, Anal eczema
- Associated Therapies
- -
Tepilta® Versus Oxetacaine, Antacids and Placebo
- Conditions
- Interventions
- First Posted Date
- 2011-04-18
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 40
- Registration Number
- NCT01336530
- Locations
- 🇦🇹
Landeskrankenhaus Feldkirch, Feldkirch, Austria
🇩🇪Strahlentherapie Coesfeld, Coesfeld, Germany
🇦🇹Universitätsklinik für Strahlentherapie-Radioonkologie, Innsbruck, Austria
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.